Trial Profile
Oxcarbazepine as an adjunct of antipsychotic therapy in acute schizophrenia
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Oxcarbazepine (Primary)
- Indications Psychotic disorders; Schizophrenia
- Focus Therapeutic Use
- 01 Jan 2009 Primary endpoint 'Additional-treatment-required' has not been met.
- 07 Apr 2008 New trial record.